POISON-GAS FROM THE AIR
Transcript of POISON-GAS FROM THE AIR
856
ANNOTATIONS
POISON-GAS FROM THE AIR
WHATEVER else remains undone, there need be nodoubt that the possibility of improving the administra-tion of poison-gas is being studied. Medical journalsabroad lay increasing emphasis on the desirability ofpractitioners familiarising themselves with the methodsof chemical warfare, and there is nowadays a wealthof information about the various agents and theiruse. It appears to be generally thought that thesedo not as yet include any that differ essentially fromthose employed in the late war. These acceptedforms of poison may be divided into (1) lacrymatorygases, chiefly used by non-military forces during civilcommotion (white cross group); (2) lung poisons suchas chlorine and phosgene (green cross); (3) arsenicalsmokes ("mask removers " or blue cross); and(4) vesicants such as mustard gas (dichlorethylsulphide) and lewisite (yellow cross). A grim mnemonicof the Germans suggests a way of remembering thedifferent effects of these groups. i
White cross reddens the whites of the eyes.Green cross turns the lungs a putrid green.Blue cross makes the nose blueish red.Yellow cross turns the skin pale yellow.
The green cross group can be neutralised by efficientchemical respirators and the arsenical smokes bymechanical respirators. As far as aerial attack isconcerned it is the yellow cross or vesicants which aremuch the greatest danger since they are liquidswhich could be dropped from the air either as a rainor in bombs and which volatilise into a heavy vapourwhich might " drown " a town or area for some days.Masks are essential for protection from the vapourand special protective clothing is necessary againstthe spray of liquid. The essence of treatment is toremove all traces of the liquid from the patient’s skinand clothing while protecting his eyes and air-passagesfrom the vapour. Speed and early treatment arevery important, and with these ends in view a chemicalwarfare treatment unit has been designed by CaptainF. A. Wells of the medical department of the UnitedStates Army.2 Two technicians of the Medical Corps,wearing impregnated clothing and head-pieces, gasmasks, and rubber gloves, strip the patient (who musthimself wear a mask)and scrub him with hand brushesirrigated with soda bicarbonate solution running froma Lyster bag suspended from the tent pole. Othersolutions which may be used are bleaching-powder,soft soap, peroxide of hydrogen, or permanganate ofpotash.3 It is claimed that a " mustard " casualtycan be cleansed by these methods in about twominutes. Such a result is attained, however, onlywith special equipment and trained personnel. Henceif it is true, as recently stated in the press, that asiittle as forty tons of gas would be needed to coverLondon with a layer of vesicant gas and that such alayer might be " canalised
" by the Thames Valleyand remain undispersed for five days or more, it isnot impossible that the population of London could beexterminated or at any rate put out of action withcomparative ease. This is, of course, disputed: ethere are authorities who think that such dangers arein practice small. One thing, however, is certain.A national scheme of anti-gas defence, to be effective,would have to include the provision and distributionof masks suitable for protection against any kind of
1 Med. Welt, March 17th, 1934, p. 382.2 Milit. Surg., February, 1934, p. 76.
3 THE LANCET, 1932, ii., 1013.
gas likely to be used, and the thorough training ofthe public in their employment, and in other anti-gasmeasures. The realisation of such a scheme, with allits implications, hardly seems to be called for underpresent conditions. On the contrary, it would beactively objectionable, since any further spread ofanti-gas drill habits must inevitably heighten the
general sense of insecurity.
ULTRA-VIOLET RADIATION FOR ERYSIPELASIN CHILDREN
THE fatality of erysipelas in children, especially ininfants, is still uncomfortably high although it hasbeen reduced by the prompt use of serum. Betterresults have however been claimed for ultra-violetradiation, and a recent paper 1 by Dr. L. M. Night.ingale and Dr. S. Starr, of Brooklyn, gives groundsfor this belief. They have treated 51 children undertwelve in this way and of these 23 were infants underone year of age. The routine employed was to givethree applications of one and a half erythema doseson successive days, regardless of the clinical course.The lamp was set at a distance of ten inches and therays were directed over an area extending one to twoinches beyond the spreading border. If the area
could be exposed only from two directions, over-
lapping was permitted. No ill-results were seen
from the radiation in the whole series. In many ofthe infants, early in the work, blood transfusion wasalso performed, but no particular benefit was observedand it was discontinued. Similarly early in the seriesserum was used in addition to the ultra-violet radia-tion for a few patients but later the latter was aloneused. The results obtained were compared withthose in 130 children with erysipelas treated by serumalone, by local treatment, by X rays, or by combina-tions of these. Some of the groups were too small tobe of value for discussion, but a broad comparisonwith the serum-treated and the radiation-treatedcases brings out certain points. Over one year ofage 47 cases received serum with a total mortality of6-4 per cent., while 28 cases received ultra-violetradiation with a total mortality of 7-1 per -cent.Under one year the respective mortalities were 59.3and 39 per cent. The authors point out, however,that death in certain instances was not due to
erysipelas but to some complicating factor such aspneumonia or mastoiditis. For example, one childwas admitted with erysipelas and pneumonia. Clini-cally the erysipelas cleared in five days but the childdied four days later of the pneumonia. Correctingthe mortality-rates on these lines they claim thatunder one year of age ultra-violet radiation treatment
gave a total recovery-rate of nearly 70 per cent. ascompared with just over 50 per cent. for serumtreatment. For the older children 2 cases out of47 died from erysipelas after serum treatment and1 out of 28 after ultra-violet radiation. There wasconsiderable difference in the length of illness in thetwo groups, especially for infants where the averageduration was only half in the ultra-violet treatedcases of what it was in those receiving serum. Wheretreatment was instituted early the differences bothin mortality and in length of illness were even morestriking, and the number of complications was ingeneral less in the irradiated cases than in thosetreated by serum. Of special interest is the youngestchild in the series. This was a premature infant,
1 Jour. Amer. Med. Assoc., March 10th, p. 761.